(Q40244928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

juvenile rheumatoid arthritis

2 March 2020

main subject

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Daniel J Lovell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Edward H Giannini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Andreas O Reiff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yukiko Kimura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Suzanne Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Philip J Hashkes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Carol A Wallace

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Dirk Foell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Richard Wu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Stephanie Biedermann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jennifer D Hamilton

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Allen R Radin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

2486-2496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

2 March 2020

cites work

1 reference

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

21 January 2018

1 reference

What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).

21 January 2018

1 reference

Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach

21 January 2018

1 reference

Development and validation of a composite disease activity score for juvenile idiopathic arthritis.

21 January 2018

1 reference

Medical treatment of juvenile idiopathic arthritis

21 January 2018

1 reference

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

21 January 2018

1 reference

The German etanercept registry for treatment of juvenile idiopathic arthritis

21 January 2018

1 reference

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

21 January 2018

1 reference

Blocking IL-1 in systemic inflammation

21 January 2018

1 reference

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

21 January 2018

1 reference

In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes

21 January 2018

1 reference

Cytokine traps: multi-component, high-affinity blockers of cytokine action

21 January 2018

1 reference

The use of anakinra in juvenile arthritis

21 January 2018

1 reference

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

21 January 2018

1 reference

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

21 January 2018

1 reference

21 January 2018

1 reference

The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.

21 January 2018

1 reference

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

21 January 2018

1 reference

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

21 January 2018

1 reference

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

21 January 2018

1 reference

The risk of infections with biologic therapies for rheumatoid arthritis

21 January 2018

1 reference

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

21 January 2018

1 reference

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

21 January 2018

1 reference

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

21 January 2018

1 reference

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

21 January 2018

1 reference

Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.38042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754188%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference